Congenital urinary tract obstruction: defining markers of developmental kidney injury

Congenital urinary tract obstruction (diagnosed antenatally by ultrasound screening) is one of the main causes of end-stage kidney disease in children. The extent of kidney injury in early gestation and the resultant abnormality in kidney development determine fetal outcome and postnatal renal function. Unfortunately, the current approach to diagnostic evaluation of the severity of injury has inherently poor diagnostic and prognostic value because it is based on the assessment of fetal tubular function from fetal urine samples rather than on estimates of the dysplastic changes in the injured developing kidney. To improve the outcome in children with congenital urinary tract obstruction, new biomarkers reflecting these structural changes are needed. Genomic and proteomic techniques that have emerged in the past decade can help identify the key genes and proteins from biological fluids, including amniotic fluid, that might reflect the extent of injury to the developing kidney

Renal tract malformations: perspectives for nephrologists.

Contains fulltext : 71176.pdf (publisher's version ) (Closed access)Renal tract malformations are congenital anomalies of the kidneys and/or lower urinary tract. One challenging feature of these conditions is that they can present not only prenatally but also in childhood or adulthood. The most severe types of malformations, such as bilateral renal agenesis or dysplasia, although rare, lead to renal failure. With advances in dialysis and transplantation for young children, it is now possible to prevent the early death of at least some individuals with severe malformations. Other renal tract malformations, such as congenital pelviureteric junction obstruction and primary vesicoureteric reflux, are relatively common. Renal tract malformations are, collectively, the major cause of childhood end-stage renal disease. Their contribution to the number of adults on renal replacement therapy is less clear and has possibly been underestimated. Renal tract malformations can be familial, and specific mutations of genes involved in renal tract development can sometimes be found in affected individuals. These features provide information about the causes of malformations but also raise questions about whether to screen relatives. Whether prenatal decompression of obstructed renal tracts, or postnatal initiation of therapies such as prophylactic antibiotics or angiotensin blockade, improve long-term renal outcomes remains unclear

Diagnosis and Treatment of Renal and Urinary Tract Malformations in Newborns

Renal and urinary tract malformations in newborns are mostly congenital anomalies with genetic bases. The routine of antenatal ultrasound (US) scans has resulted in the early detection of these conditions and in selected cases has led to the development of prenatal management strategies including fetal intervention and/or the organization of the diagnostic procedures, postnatal surgical intervention, and/or clinical follow-up. In minor cases, where diagnosis is not allowed during prenatal life, it may be obtained after a postnatal routine follow-up or subsequently a clinical complication, generally urinary tract infection (UTI